New drug trial offers hope for Tough-to-Treat bile duct cancers
NCT ID NCT05297903
Summary
This study is testing an experimental drug called XmAb20717 for people with advanced bile duct or gallbladder cancer that has worsened after standard chemotherapy. It involves 27 participants who will receive the drug to see if it can shrink tumors or slow cancer growth. The goal is to find a new treatment option for patients who have run out of standard choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.